Takeda Pharmaceutical Li... (TAK)
NYSE: TAK
· Real-Time Price · USD
15.19
0.19 (1.27%)
At close: Aug 18, 2025, 3:59 PM
15.20
0.10%
Pre-market: Aug 19, 2025, 07:00 AM EDT
Takeda Pharmaceutical Revenue
Takeda Pharmaceutical reported an annual revenue of $4,581.6B, reflecting a 7.45% growth. For the quarter ending March 31, 2025, Takeda Pharmaceutical generated $1,053.4B in revenue.
Revenue (ttm)
4,581.6B
Revenue Growth
7.45%
Price / Sales Ratio
1.56
Revenue / Employee
92.97M
Employees
49,281
Market Cap
47.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2025 | 4,581.6B | +7.45% |
| Mar 31, 2024 | 4,263.8B | +5.87% |
| Mar 31, 2023 | 4,027.5B | +12.85% |
| Mar 31, 2022 | 3,569B | +11.61% |
| Mar 31, 2021 | 3,197.8B | -2.84% |
| Mar 31, 2020 | 3,291.2B | +56.93% |
| Mar 31, 2019 | 2,097.2B | +18.45% |
| Mar 31, 2018 | 1,770.5B | +2.22% |
| Mar 31, 2017 | 1,732.1B | -4.17% |
| Mar 31, 2016 | 1,807.4B | +1.66% |
| Mar 31, 2015 | 1,777.8B | +5.09% |
| Mar 31, 2014 | 1,691.7B | +8.63% |
| Mar 31, 2013 | 1,557.3B | +3.20% |
| Mar 31, 2012 | 1,508.9B | +6.31% |
| Mar 31, 2011 | 1,419.4B | -3.18% |
| Mar 31, 2010 | 1,466B | -4.70% |
| Mar 31, 2009 | 1,538.3B | +11.90% |
| Mar 31, 2008 | 1,374.8B | +5.34% |
| Mar 31, 2007 | 1,305.2B | +7.67% |
| Mar 31, 2006 | 1,212.2B | +7.95% |
| Mar 31, 2005 | 1,123B | +3.36% |
| Mar 31, 2004 | 1,086.4B | +3.86% |
| Mar 31, 2003 | 1,046.1B | +4.08% |
| Mar 31, 2002 | 1,005.1B | +4.32% |
| Mar 31, 2001 | 963.48B | +4.37% |
| Mar 31, 2000 | 923.13B | n/a |